Skip to main content

Towards a better understanding of Fagopyrum dibotrys: a systematic review


Fagopyrum dibotrys (F. dibotrys) (D.Don) H.Hara is a well-known edible herbal medicine in Asian countries. It has been widely used for the treatment of lung diseases, swelling, etc., and is also an important part of many Chinese medicine prescriptions. At present, more than 100 compounds have been isolated and identified from F. dibotrys, and these compounds can be primarily divided into flavonoids, phenols, terpenes, steroids, and fatty acids. Flavonoids and phenolic compounds are considered to be the main active ingredients of F. dibotrys. Previous pharmacological studies have shown that F. dibotrys possesses anti-inflammatory, anti-cancer, anti-oxidant, anti-bacterial, and anti-diabetic activities. Additional studies on functional genes have led to a better understanding of the metabolic pathways and regulatory factors related with the flavonoid active ingredients in F. dibotrys. In this paper, we systemically reviewed the research advances on the phytochemistry and pharmacology of F. dibotrys, as well as the functional genes related to the synthesis of active ingredients, aiming to promote the development and utilization of F. dibotrys.


Fagopyrum dibotrys (F. dibotrys) (D.Don) H.Hara, also called Fagopyrum acutatum (Lehm.) Mansf. ex K.Hammer, is a perennial herb of the dicotyledonaceae family Polygonaceae [1]. F. dibotrys is widely distributed across the North temperate zone and is mainly grown in China, India, Thailand, and Vietnam. China is documented to be the main distribution region of F. dibotrys, and wild F. dibotrys has been listed as a national second-level protected plant [2]. It has been approved as a functional food by the National Health and Family Planning Commission of the People’s Republic of China [3]. The grains of F. dibotrys are common food product used to make side dishes, flour, and tea, and its stem and leaf are used as forage feed resources.

In addition to the nutritional and economic values, the rhizome of F. dibotrys is also used as a traditional Chinese medicine for a long history [3, 4]. According to the Pharmacopoeia of China (2020 edition), the rhizome of F. dibotrys possesses the effects of clearing away heat and detoxification, expelling pus and removing blood stasis, and is recommended for diseases such as lung abscesses, measles pneumonia, swelling and pain in throat and dysmenorrhea, inflammation, and so on. It is also an important part of many famous traditional Chinese medicine prescriptions such as Wei Mai Ning Capsule and Ji Zhi Tang Jiang.

In the past decades, phytochemical researches on F. dibotrys have identified more than 100 compounds, mainly including flavonoids, phenolics, triterpenoids and tannins, supporting its potential to be developed as a health care product and functional food [5]. Pharmacological studies have revealed that F. dibotrys possesses anti-inflammatory, anti-cancer, anti-oxidant, anti-bacterial, and anti-diabetic activities. The main bioactive components related with these pharmacological activities have been investigated, as well as the underlying mechanisms. Besides, with the developments in molecular biology technology, research into the functional genes helps to elucidate the biosynthetic pathways and regulatory mechanisms of active ingredients in medicinal plants. Additional studies on functional genes have led to a better understanding of the metabolic pathways and regulatory factors related with the active ingredients in F. dibotrys.

This article reviews research progress regarding the chemical compositions, pharmacological activities, and functional genes of F. dibotrys, aiming to provide critical information for further research on F. dibotrys.

Fagopyrum species

Fagopyrum dibotrys belongs to the genus Fagopyrum (family Polygonaceae) which comprises more than ten species of plants. Among the Fagopyrum species, Fagopyrum esculentum (F. esculentum) (common buckwheat), Fagopyrum tataricum (F. tataricum) (tartary buckwheat), and F. dibotrys (golden buckwheat) attract increasing attention owing to their long history of both edible and medicinal uses [1]. These three Fagopyrum species share similarities in nutritional and medicinal values, whereas there are also many differences between them.

Fagopyrum esculentum and F. tataricum are annual herbs with small white or pinkish flowers and edible triangular seeds, while the seeds of F. tataricum are smaller than that of F. esculentum. F. esculentum and F. tataricum are extensively produced and consumed as the main buckwheats worldwide with more than 4000 years cultivation [6]. Compared with F. tataricum, the seed of F. esculentum has advantages of sweet taste, large size, and easy dehulling of seed coat. However, detailed comparison studies indicated that the nutritional value of F. tataricum is much higher than F. esculentum. F. tataricum is richer in nutrients and antioxidants, such as vitamin B and rutin, and has good medicinal potential [7, 8]. The antioxidant potential, total phenolic content, and total flavonoid content of F. tataricum are much higher compared to F. esculentum [6]. In contrast, F. dibotrys is a perennial wild herb with the characteristics of a thick main root, whorls, and large achenes. Similarly, the seeds of F. dibotrys are also edible, and its stem and leaf are also documented to be good forage feed resources [3]. Its leaves are rich in rutin, making it a healthy addition to diet, and can be boiled or steamed like spinach.

The existing methods to distinguish the buckwheat varieties mainly include morphology, allozyme variability, restriction fragment length polymorphism of chloroplast DNA, rbcL-accD region nucleotide sequence of chloroplast DNA, and nucleotide sequences of the ITS region of rRNA gene, etc. [9, 10]. The use of chloroplast DNA sequence data plays an important role in illuminating the phylogeny of buckwheat species. Previously, the chloroplast DNA sequence of F. dibotrys has been well investigated, and the chloroplast DNA size is detected to be 159,320 bp. Compared with the chloroplast DNA of other buckwheat species, F. dibotrys was more conserved with several variation hotspots [2]. Wang et al. [11] analyzed the complete chloroplast DNA of two cultivated buckwheat F. tataricum and F. esculentum together with two wild type F. dibotrys and F. luojishanense. Their results indicated that F. dibotrys is more closely related to Fagopyrum tataricum. By determining the DNA sequences of rbcL and accd59 coding regions and their intergenic regions in multiple taxa of Fagopyrum, it was found that the evolution speed of accd59 coding region and intergenic region were about 5 times that of the rbcL coding region. F. dibotrys has multiple polyploids, and F. dibotrys and F. tataricum are closely related [12]. However, owing to the incomplete sampling, insufficient chromosome and phylogenetic markers, and complex evolutionary issues, the phylogenetic relationships, metabolism and genome comparisons among the Fagopyrum species are still not fully understood, and much more work are needed.

Ethnomedicinal uses of F. dibotrys

Compared with F. esculentum and F. tataricum, F. dibotrys is more famous for its ethnomedicinal uses. F. dibotrys is an important crude drug which has been widely recorded in a series of Chinese medicine books, such as New Compilation of Materia Medica, Supplements to Compendim of Materia Medica. In China, the rhizome F. dibotrys is used as a folk herbal medicine for the treatment of lung disease, swelling and pain in throat and dysmenorrhea, inflammation, dysentery, and so on. In the Chinese Pharmacopoeia, F. dibotrys has been recorded to possess effects of heat-clearing and detoxicating, abscess and stasis removing.

Fagopyrum dibotrys is also an important part of many modern Chinese patent medicine formulations, such as Wei Mai Ning Capsule, Ji Zhi Tang Jiang, Fu Ping Jiao Nang, Jin Hua Ming Mu Wan, Chang Xin Jiao Nang, Jin Ci Can Jiu Zheng He Ji, etc. (Table 1). Thereinto, Wei Mai Ning Capsule which contains extract of F. dibotrys as the main raw material has been approved and clinical used as an alternative cancer treatment and is documented to increase the efficacy and reduce the toxicity of radiotherapy and chemotherapy. Ji Zhi Tang Jiang (consists of Houttuyniae, F. dibotrys, Ilicis Chinensis Folium, etc.) is a very famous over-the-counter drug which is effective in expectorating and relieving cough, and Fu Ping Jiao Nang (consists of F. dibotrys, Viola yedoensis makino, Rhizoma curcumae, etc.) is used in clinic for diseases such as pelvic inflammation and accessory inflammation.

Table 1 The ethnomedicinal uses of Fagopyrum dibotrys


The phytochemicals distributed in F. dibotrys have been widely studied in the past decades. To date, a number of compounds with diverse structures have been isolated from F. dibotrys, primarily including flavonoids, phenolics, triterpenoids, tannins, steroids, fatty acid, etc. Essential volatile oils of F. dibotrys consist of aliphatic compounds, aromatic compounds, and sulfur-containing nitrogen compounds. Compounds that have been isolated and identified are listed in Table 2, and relative structures of these compounds are shown in Fig. 1.

Table 2 Phytochemistry of Fagopyrum dibotrys
Fig. 1

Chemical structures of the components isolated from Fagopyrum dibotrys


Flavonoids are naturally occurring polyphenolic compounds characterized by a carbon-based skeleton (C6–C3–C6) [13] and are widely presented in Chinese herbal medicines. Flavonoids have been shown to be the major active ingredients in F. dibotrys. The content of flavonoids in F. dibotrys is higher than that found in other buckwheat cultivars. To date, more than 30 flavonoids have been isolated from F. dibotrys, such as quercetin and rutin. In addition, catechins, (+)-catechin, and (−)-epicatechin, have also been isolated from F. dibotrys. These isolated flavonoids are listed in Table 2.


Phenolics refer to nonpolymeric phytochemical compounds that contain at least one phenolic hydroxyl located on the same benzene ring [14]. Phenolics are widely distributed in plants and have a variety of physiological activities. To date, about 20 phenolics have been identified from F. dibotrys. The main phenolic compounds are derivatives, such as benzoic acid and 3,4-dihydroxy benzoic acid. In addition, phenolic compounds such as gallic acid, succinic acid, syringic acid, and ferulic acid can be used directly in various applications.


Tannins contain polyphenols and are widely reported to scavenge free radicals and prevent oxidation [15]. Seven tannins have been isolated from F. dibotrys. Among them, 3,3′-di-O-galloyl-procyanidin B-2 and 3′-O-galloyl-procyanidin B-2 are rich in hydroxyl groups.


According to previous reports, a total of five triterpenoids have been extracted from F. dibotrys: glutinone, glutinol, 3α,21β-dihydroxy-olean-12-ene, olean-12-ene- 3β,7β,15α,28-tetraol, and ursolic acid.


Aside from the compounds mentioned above, several steroids have also been identified from F. dibotrys, mainly including 3α-hydroxy-urs-12,15-dien, Hecogenin, β-sitosterol, N-butanol-β-d-furan methylglycoside, n-butyl-β-d-fructopyronoside, β-daucosterol, and daucosterol.

Volatile oils

Essential volatile oils consist of aliphatic compounds, aromatic compounds, terpenes (oxymonoterpenes, monoterpenes and oxygen sesquiterpenes), and sulfur-containing nitrogen compounds. To date, more than forty constituents have been isolated from F. dibotrys. Eugenol, α-terpineol, nonanal, (E)-3-Hexen-1-ol and ethyl cinnamate are the main components. In addition, different types of volatile oils derived from F. dibotrys have been shown to have anti-bacterial and anti-oxidant effects [16]. More detailed information on volatile oils can be found in Table 3, and their structures are listed in Fig. 2.

Table 3 Components isolated from the volatile oil of Fagopyrum dibotrys
Fig. 2

Chemical structures of the components isolated from the volatile oil of Fagopyrum dibotrys

Other compounds

In addition to the above components, F. dibotrys contains many other compounds, such as emodin, emodin-8-O-β-d-glucopyranoside, N-trans-coumaroyl tyramine, (3-methoxyphenyl)-2-piperidinemethanol, n-butyl-β-d-fructopyronoside and 5,5′-di-α-furaldehyde dimethyl ether. According to previous studies [17], F. dibotrys is also rich in protein, starch, fat, crude fiber, vitamins, and mineral elements. Table 2 contains information on these additional compounds.

Pharmacological activities

Due to its rich chemical composition, F. dibotrys has been reported to possess a variety of pharmacological activities, including anti-inflammatory, anti-cancer, anti-oxidant, anti-viral, anti-diabetic and anti-bacterial activities (Fig. 3). This review summarizes the various biological activities of F. dibotrys extracts and relative compounds (Table 4), which is conducive to further research on F. dibotrys.

Fig. 3

Pharmacological activities of Fagopyrum dibotrys

Table 4 The pharmacological activities and mechanisms of the extracts and pure compounds from Fagopyrum dibotrys

Anti-inflammatory activity

Inflammation represents a defense mechanism of different organisms to various harmful stimuli [18]. Ethanol extract of F. dibotrys has been shown to exert anti-inflammatory effects in the treatment of colitis and arthritis. F. dibotrys extract can reduce lipopolysaccharide (LPS) levels, thereby inhibiting NF-κB p65 nuclear translocation and IκB phosphorylation and improving LPS-induced cell proliferation. At the same time, F. dibotrys extract can also reduce levels of pro-inflammatory cytokines and be used as a treatment for ulcerative colitis [4]. In cases of inflammatory bowel disease induced by dextran sodium sulfate, F. dibotrys can down-regulate tumor necrosis factor-α (TNF-α), as well interleukin (IL)-6, IL-1β and IL-10. By reducing expression of these inflammatory factors, F. dibotrys can thereby prevent and reduce inflammatory symptoms and damage [19]. In both in vivo and in vitro experiments, F. dibotrys has been shown to have a therapeutic effect on irritable bowel syndrome by up-regulating expression of claudin-1, claudin and ZO-1 tight junction proteins in colon epithelial cells, thereby reducing intestinal inflammation and enhancing mucosal epithelial function [20]. Shen et al. proved that F. dibotrys can inhibit experimental arthritis and reduce inflammation [21]. In experimental arthritis rats, F. dibotrys extract was shown to inhibit swelling and weight loss, reduce plasma viscosity, and significantly reduce production of proinflammatory cytokines IL-1 and TNF-α in serum. Treatment with F. dibotrys has also been shown to exert a protective effect on the lung tissue of rats with Klebsiella pneumonia [22].

The anti-inflammatory activity of F. dibotrys is primarily derived from the monomer compounds isolated from it. Previous in vitro and in vivo experiments have demonstrated that anti-inflammation is one of the main pharmacological effects of luteolin, and the main mechanism include regulation of transcription factors STAT3, NF-κB and AP-1 [23]. Isorhamnetin, another flavonoid compound isolated from F. dibotrys, has been proven to inhibit LPS-induced inflammation in human gingival fibroblasts by activating the Nrf2 signaling pathway [24]. Chrysoeriol can improve TPA-induced acute skin inflammation in mice, and thus also has an anti-inflammatory effect [25]. Tricin exerts anti-inflammatory effects through a mechanism involving TLR4/NF-κB/STA, which has protective effects on LPS-induced human peripheral blood mononuclear cells (hPBMCs) and carrageenan-induced rats [26]. Hesperetin and Kaempferol are also proved to modulate expression of pro-inflammatory cytokines and chemokines [27]. In the treatment of rheumatoid arthritis, protocatechuic acid can inhibit secretion of inflammatory cytokines, such as TNF-α, IL-1β and IL-6 [28]. Similarly, hecogenin can reduce production of TNF-α and IL-12 in Balb/c mice; when used in combination with flutica, it has a significant effect on skin inflammation and bronchitis [29]. In paraquat-induced acute lung injury in rats model, Procyanidin B2 was found to ameliorate oxidative stress, inhibit the expression of IL-1β and IL-18, and significantly reduce paraquat-induced activation of inflammatory factors in lung tissue [30]. Procyanidin B1 can negatively regulate the TLR-MyD88 signaling pathway and inhibit LPS-mediated inflammation [31]. Procyanidin can inhibit the activity of ERK1/2 and IKKβ to reduce production of LPS-induced production of reactive oxygen species, thereby exerting an anti-inflammatory effect [32].

Anti-cancer activity

In the past decades, the anti-cancer activity of F. dibotrys has received more and more attention. Many studies have demonstrated that F. dibotrys and its components exhibit significant in vitro and in vivo inhibitory effects in various cancer types. F. dibotrys extract treatment could inhibit the growth of various cancer cells including lung cancer (H460), liver cancer (HepG2), leukocytes (K562), colon cancer (HCT116) and bone cancer (U2OS) [33]. F. dibotrys extract administration can inhibit the transplant ability of S180 sarcoma, Lewis lung cancer and U14 cervical cancer in mice models [24, 34]. Fr4 represents the fourth fraction isolated from F. dibotrys extract with more than 50% polyphenol content, it can down-regulate expression of matrix metalloproteinase (MMP)-9 and significantly inhibit the progression of Lewis lung cancer in mice [35].

Cancer prevention and treatment using combination therapy with Chinese medicines have been proposed as an effective strategy in clinic during the past years [36, 37]. Particularly, F. dibotrys extract in combination with other drugs have been documented to increase the efficacy and reduce the toxicity of radiotherapy and chemotherapy. Wei Mai Ning Capsule which contains extract of F. dibotrys as the main raw material has been approved for clinical cancer therapy. Combination of extracts from Rosa roxburghii Tratt and F. dibotrys significantly promoted apoptosis and inhibited growth of human esophageal squamous cell carcinoma CaEs-17, human gastric cancer SGC-7901 and lung cancer A549 cells [38]. The combination of daunorubicin and F. dibotrys extract has also been shown to have a synergistic effect.

The main components responsible for the anti-cancer activity of F. dibotrys have been investigated, as well as the underlying mechanisms. β-sitosterol (β-SITO), a compound found in F. dibotrys, has been demonstrated to decrease the viability of breast cancer MCF-7 cells, and immunofluorescence analysis confirmed the tubulin-targeted anticancer potential of β-SITO [39]. (−)-Epicatechin has been reported to suppress cancer cell proliferation through the MAP kinase pathway. (−)-Epicatechin treatment significantly improves the clone survival rate of normal human skin fibroblasts exposed to radiation, supporting its potential to be used both as a preventive agent and as an adjunct to chemotherapy and radiotherapy [40]. Murexin and Isovitexin have also been recorded to show anti-cancer activity in various cancer cells [41]. Rhamnetin treatment significantly promotes expression of P5 protein and miR-34a, subsequently inhibit the expression of Notch1 and suppress the proliferation of MCF-7 cells [42]. Isorhamnetin can down-regulate the expression of cyclin A to cause S-phase arrest and reduce the migration of advanced pancreatic cancer cells [43]. Genkwanin can significantly inhibite proliferation of human colorectal cancer HT-29 and SW-480 cells. Oral administration of genkwanin can improve the spleen and thymus indexes of the mice, as well as immune cytokine secretion, supporting genkwanin to be an effective compound for colorectal cancer [44]. Many studies have revealed the anti-cancer effect of hesperetin, which can down-regulate expression of glucose transporters to reduce the glucose uptake of cancer cells, thereby suppressing their proliferation. Hesperetin treatment can also inhibit cell migration by inhibiting TGF-β signaling [45]. In addition to anti-inflammatory effects, kaempferol also exhibits anti-cancer activity. Kaempferol treatment can induce G2/M phase cell cycle arrest and promote apoptosis in skin cancer and colon cancer cells [46]. Ursolic acid is a natural compound that exists widely in functional food including F. dibotrys and previous studies have shown that ursolic acid can block the G1/G2 cell cycle and induce breast cancer cell apoptosis [47]. Moreover, using the H-RS cell line, researchers found that procyanidin B2 can prevent the binding of NF-κB to DNA, inhibiting NF-κB-driven expression of genes including anti-apoptotic proteins [48].

Anti-oxidant activity

Fagopyrum dibotrys contains a high concentration of polyphenols and flavonoids, which possess the ability to scavenge free radicals and superoxide anions. It has been documented to exhibit strong anti-oxidant capacity [49]. This anti-oxidant activity can be enhanced by the presence of two or three adjacent phenolic hydroxyl groups in the molecular formula [38, 50]. Many compounds identified in 60% of water acetone extracts were able to scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radicals and showed significant anti-oxidant activity [50]. Compared with the positive control vitamin C, quercetin, dimethylquercetin and gallic acid found in F. dibotrys extract exhibited stronger anti-oxidant activity, and the ability of 6-O-galloyl-d-glucose to scavenge free radicals is even higher than that of vitamin C. Extracts of different parts of F. dibotrys have different anti-oxidant properties, with leaf extract showing the strongest anti-oxidant properties [51].

Hesperidin has a variety of biological activities, especially anti-inflammatory effects which is manifested in two main aspects: scavenging free radical activity and increasing the defense ability of anti-oxidant cells through the ERK/Nf2 signaling pathway [52]. Ferulic acid is widely used in cosmetics because of its anti-oxidant activity. In addition to scavenging free radicals, ferulic acid can also enhance the enzymatic activity of free radical scavengers and inhibitors [53]. Isorhamnetin treatment of a LPS-induced acute lung injury (ALI) mouse model indicated that isorhamnetin can inhibit activation of COX-2 and reduce the oxidative stress response induced by LPS, thereby preventing LPS-induced ALI [54]. Researchers also found that procyanidin B2 can inhibit H2O2-induced 8-oxo-7,8-dihydro-2 V-deoxyguanosine in human leukemia cell line HL-60. However, at high concentrations, it will increase the formation of 8-oxodG in HL-60 cells. Experiments with calf thymus DNA showed that procyanidin B2 reduced the M4PO-OH signal of H2O2 and Fe(II), but enhanced H2O2 and Cu(II) signals and induced DNA damage. Therefore, procyanidin B2 may interact with H2O2 and metal ions to exert both anti-oxidant and pro-oxidant effects [55].

Anti-bacterial activity

The ethyl acetate extract of F. dibotrys has been proved to exhibit obvious anti-bacterial effect against Streptococcus haemolyticus B and pneumococcus in vitro. In vivo, the extract had an obvious protective effect on mice infected by pneumococcus. Based on the previous reports, the main anti-bacterial compounds are believed to be the phenolic acids, flavonoids and flavanol compounds [56]. The combined use of F. dibotrys and levofloxacin can improve the treatment efficacy of acute bacterial dysentery [57]. Studies have shown that F. dibotrys can be used to treat the lung tissue damage caused by Klebsiella pneumoniae by reducing expression of TNF-α, ICAM-1, NF-κB p65 and MIP-2 [22]. In another study, F. dibotrys was formulated into ultrafine powder and used at high, medium and low doses in mice infected with Salmonella. The results demonstrated that the ultrafine F. dibotrys powder had a protective effect on mice infected with Salmonella and suggested a dose-activity relationship [58].

Due to the abuse of antibiotics, antibiotic resistance has become a major threat to public health [59]. Discovery of natural products represents a compelling solution. β-SITO has been revealed to exhibit inhibitory effect on Streptococcus pneumoniae. β-SITO directly attacks the pneumolysin, the main virulence factor of pneumococcus, through two action sites (Thr459 and Leu460) to prevent cell lysis [44]. In studying the effect of β-SITO on mouse colitis, researchers found that it can significantly increase the expression of anti-microbial peptides in intestinal epithelial cells and reduce the survival rate of Salmonella typhimurium [60]. Emodin inhibits Haemophilus parasui by interacting with the cell membrane or proteins on the cell wall to change the conformation of membrane proteins [61]. Bacterial RecA stress stimulates DNA repair pathways, which are closely related to antibiotic resistance. P-coumaric acid is an effective RecA inhibitor, and has been shown to inhibit the biochemical activity driven by RecA and interfere with the DNA binding domain of the RecA protein [62].

Anti-viral activity

Since the treatment of viral influenza with chemical drugs is prone to induce adverse reactions, such as drug resistance [63], more and more attention is now being paid to the use of traditional Chinese medicines as anti-viral treatments. Flavonoids from natural products have been widely reported to possess anti-viral potential [64]. Flavonoids also represent the main anti-viral components of F. dibotrys. Zhao et al. evaluated the anti-viral potential of F. dibotrys using both the hemagglutination test and a cell culture method, their results indicated F. dibotrys has anti-viral activity in vitro, and this activity is dependent on the dose of F. dibotrys flavonoids [65].

African swine fever virus (ASFV) is a serious threat to pig breeding due to the lack of effective treatment measures. In vitro experiments have shown that genkwanin can reduce protein levels and DNA synthesis in both early and late stages of ASFV, in addition to inhibiting the ASFV Ba71V strain in Vero cells [66]. Tricin has been proved to exhibit inhibitory effect against influenza virus by reducing expression of hemagglutinin and matrix protein in influenza virus-infected cells, as well as reducing the expression of HA and M messenger RNA. In addition, tricin has a positive effect on the body weight and survival rate of infected mice in a mouse model of influenza virus infection [67]. Recent study reported that ursolic acid has the potential to resist rotavirus, hindering early virus replication [68]. Procyanidin B1 was documented to be a new therapeutic agent for hepatitis virus C (HCV) treatment. It was found to inhibit the synthesis of HCV RNA in a dose-dependent manner, thereby preventing vesicular stomatitis virus and showing an inhibitory effect on HCV pseudo virus-infected Huh-7 cells [69]. The feline calicivirus (FCV)-F9 and murine norovirus (MNV)-1, both of which are alternatives to human norovirus (HNoV), were selected to test the anti-viral activity of procyanidin B2. It was found that procyanidin B2 can reduce the concentrations of both FCV-F9 and MNV-1 to undetectable levels. In addition, protocyanidin B2 was shown to bind directly to the main capsid structure of HNoV, namely the P domain, thus significantly changing the tertiary structure of the virus-like particles [70].

Anti-diabetic activity

Previous studies indicated that reactive oxygen radicals and their oxidation reactions can damage islet β cells, leading to diabetes [71]. F. dibotrys extract is rich in amino acids and vitamins which can scavenge free radicals, reducing damage to the body and achieve anti-diabetic effects. Treatment with 50–200 mg/kg F. dibotrys flavonoids is effective in type 2 diabetic mice. In T2DM mice, this treatment can reduce blood glucose and insulin levels, increase body weight and regulate blood lipid metabolism and oxidative stress [72]. In vitro studies have revealed that ursolic acid can inhibit the related protein tyrosine phosphatase 1B, which leads to down-regulation of insulin receptors. Controlled clinical trials in patients with metabolic syndrome indicated that, compared to the placebo group, patients treated with oral ursolic acid showed relieved symptoms, increased insulin sensitivity and reduced concentration of fasting blood glucose [73]. Procyanidin C1 can improve differentiation of 3T3-L1 adipocytes and activate the AKT-eNOS pathway, thereby promoting insulin-induced glucose uptake in cells and increasing insulin sensitivity [74]. Moreover, in diabetic rats, P-coumaric administration led to a significant reduction in the levels of glucose and glycosylated hemoglobin, as well as induced significant increases in insulin and body weight. Additional anti-diabetic mechanisms of P-coumaric acid include reduced levels of TNF-α and increased levels of adipocytokines and PPARγ [75].

Other activities

In addition to the above pharmacological activities, F. dibotrys also has several other activities. F. dibotrys contains a lot of polyphenolic compounds and has obvious anti-tussive and expectorant effects [76]. It also has a neuroprotective effect and can cross the blood-brain barrier to penetrate and accumulate in the brain. Therefore, F. dibotrys has a therapeutic effect on Alzheimer’s disease (AD) [77]. After intragastric administration of F. dibotrys flakes to rats, the collected serum can inhibit the contraction of guinea pig ileum in vitro [78]. In addition, F. dibotrys has an anti-mutagenic effect on mutations of TA98 and TA100 strains induced by orthodoxin and methanesulfonate [79].

Fagopyrum dibotrys extract has therapeutic potential for neurodegenerative diseases, and vitexin is suggested to be one of the main active compounds. Vitexin can increase neuroprotective factors and counteract the induction of neurodegeneration. Ferulic acid is also considered to be a promising treatment for AD [80]. Ferulic acid can reduce the oxidative stress response in AD and protect the brain from Aβ neurotoxicity [81]. The neuroprotective effects of procyanidin B2 evaluated in rat cerebellar granule neurons, the results indicated that procyanidin B2 exhibited neuroprotection effect by scavenging reactive oxygen and nitrogen [82]. Procyanidin C1 has been proved to act on glutamate-induced HT22 cells to significantly reduce cell death. This compound also possesses free radical scavenging activity, inhibiting the accumulation of reactive oxygen species and protein carbonylation in cells induced by glutamate, thus exhibits neuroprotective effect on HT22 cytotoxicity induced by glutamate [83].

Functional genes

At present, research into medicinal plants primarily focuses on extraction and separation technology, effective ingredient analysis and assessment of pharmacological activity [78]. With increasing clinical demand for medicinal plants and the development of molecular biology techniques, research into functional genes related to the synthesis of active pharmaceutical ingredients has attracted significant interest. The research into functional genes of medicinal plants mainly emphasizes the investigation of the genes encoding key enzymes that play an important role in regulating the synthesis of secondary metabolites [84]. Secondary metabolites are produced by medicinal plants that have adapted to the environment in order to survive, and are divided into phenols, alkaloids, terpenes, etc. [85]. Previously, the functional genes of F. dibotrys have been studied, the genes related with the secondary metabolites of F. dibotrys have been discovered as well as the relevant metabolic pathways. Relative studies play an important role in research into the active ingredients of F. dibotrys. F. dibotrys contains many flavonoids, and its biological activity and synthetic pathways have received extensive attention. At present, the research into functional genes of F. dibotrys is primarily focused on flavonoids.

Anthocyanins are flavonoids, and the anthocyanin synthase (ANS) gene is critical to the anthocyanin synthesis pathway in golden buckwheat. The anthocyanin synthase (FdANS) gene was obtained from F. dibotrys for the first time using homologous cloning technology. Bioinformatics showed that the protein encoded by the FdANS gene was homologous to the ANS genes of other medicinal plants. The expression levels of FdANS in different tissues were analyzed; the results showed that the level of FdANS was flower > leaf > stem > root, but the amount of anthocyanin was flower > leaf > stem > root. The amount of penicillin is correlated [86]. The rhizome of F. dibotrys contains a lot of procyanidins (PAs). A radiation-induced mutant (RM_R) obtained by Chen et al. [3] contained higher procyanidins than wild-type (CK_R). RNA-seq was used to compare rhizome transcripts between the two strains. This analysis involved a total of 53,540 genes, of which 29,901 were annotated and analyzed. This analysis found that some of the single genes encoding PAs biosynthetic enzymes are different between RM_R and CK_R, with 501 unique sequences encoding the differential expression of single genes encoding TFs between RM_R and CK_R samples. Accumulation of cytochrome P450s in flavonoids, detected by qRT-PCR, showed the expression of twelve key genes related to flavonoid biosynthesis and was consistent with the RNA-seq results. Therefore, radiation increased the expression of PA synthesis-related genes, and accumulation made the PA content in RM_R higher than in the buckwheat rhizome of CK_R.

Dihydroflavonol 4-reductase (DFR) is a key enzyme for procyanidin synthesis. Using the RACE method combined with cDNA library screening, the DFR (FdDFR) gene was cloned from F. dibotrys. The DFR gene in the F. dibotrys genome is a small family of 1 to 2 genes. FdDFR1 is a single copy gene and is homologous to DFR genes of other medicinal plants [87]. A mixture of procyanidin-condensed tannin is one example of a secondary metabolite of flavonoids [34]. The leucoanthocyantin reductase (LAR) gene encodes a key enzyme in the synthesis of flavonoids. It was obtained from F. dibotrys by PCR and RACE. By using real-time fluorescence quantitative PCR technology, researchers found that the FdLAR gene was related with the accumulation of secondary metabolites of buckwheat flavonoids [88]. In addition, the chalcone isomerase (CHI) gene also plays an important role in the F. dibotrys flavonoid synthesis pathway [34]. The cDNA sequence of the CHI (FdCHI) gene was obtained from F. dibotrys by using homologous cloning technology. Bioinformatic analysis showed that the protein encoded by the FdCHI gene was homologous to the CHI genes of other medicinal plants, and FdCHI was expressed in different tissues of F. dibotrys. The results showed that expression of FdCHI was flower > root > leaf > stem, while total flavonoid content was flower > leaf > stem > root. This suggests that expression of FdCHI is related to the total flavonoid content in flowers, leaves and stems, but is less relevant in the root [89].

Rutin is another secondary metabolite in F. dibotrys. Rutin belongs to the flavonoid family, and its synthesis is inseparable from that of phenylalanine ammonia lyase (PAL). Through homologous cloning and RT-PCR technology, the DNA sequence of the F. dibotrys PAL gene was measured to be 2583 bp. The cDNA sequence contained an open reading frame of 2169 bp, encoding 722 amino acids. After synthesis, the acid was converted to cinnamic acid [65]. The specific characteristics of the PAL gene sequence can be used for the genetic improvement of golden buckwheat [90]. Flavanol synthase (FLS) enzyme and dihydroflavonol form quercetin through an oxidation reaction. It has been reported that the FLS gene is encoded by multiple gene copies, and the same copy can be found in different medicinal plants [91, 92]. Using homologous cloning technology, the FLS (FdFLS) gene was cloned and the cDNA sequence of FdFLS in F. dibotrys was determined [93].

Many transcription factors also play important roles in the F. dibotrys flavonoid synthesis pathway. Some studies have used RACE combined with a cDNA library screening method to clone the transcription factor gene MYBP1 (FdMYBP1) from F. dibotrys. Through southern hybridization and bioinformatics analysis, researchers revealed that FdMYBP1 gene exists in one to two copies, equal to MYB based on structural characteristics of the source gene, it is believed that FdMYBP1 plays a vital role in flavonoid metabolism [94].

Discussion and future perspectives

Fagopyrum dibotrys is a famous edible herbal medicine widely used in traditional Chinese medicine. In China, F. dibotrys has been used for a long time to treat diseases such as pneumonia and tonsil swelling. As a traditional Chinese medicine, F. dibotrys is an important component of many Chinese medicine formulas, including Wei Mai Ning Capsule, Ji Zhi Tang Jiang, and Jin Hua Ming Mu Wan. To date, more than 70 chemical components have been isolated from F. dibotrys, together with nearly 50 components from the volatile oil. However, investigation on the whole chemical components of F. dibotrys is far from finish up completely. With the development of modern science and technologies in rapid and efficient separation and identification of complex chemical compounds from natural products [95], it is expected that more unknown compounds will be separated and identified from F. dibotrys using technologies such as multi-dimensional liquid phase chromatography combined with mass spectrometry. Better understanding on phytochemistry will undoubtedly promote the further investigation of golden buckwheat.

Previous research on the pharmacological activity of F. dibotrys has characterized its multiple effects which partially support its traditional uses. For example, a series of pharmacological studies focused on the anti-inflammatory activity of F. dibotrys and have proved its therapeutic potential in lung abscesses, irritable bowel syndrome, etc. The extracts of F. dibotrys and isolated compounds including hecogenin, luteolin, isorhamnetin and chrysoeriol have been demonstrated to suppress secretion of inflammatory cytokines and inhibit related pathways in relevant in vitro and in vivo models. Besides, according to the ethnomedicinal uses in China, Jin Ci Can Jiu Zheng He Ji, which is composed of Rosa roxburghii, Sophora flavescens and F. dibotrys, has been clinically used in adjuvant therapy for radiotherapy and chemotherapy. Accordingly, modern pharmacological studies demonstrated that the extracts and monomers of F. dibotrys exhibited anti-cancer activities in various cancer types in vitro and in vivo. Furthermore, Wei Mai Ning Capsule has been clinical used to increase the efficacy and reduce the toxicity of radiotherapy and chemotherapy. However, the main components responsible for the anti-cancer potential of F. dibotrys are not fully clarified, as well as the underlying molecular mechanisms. With the widespread application of targeted therapy and immunotherapy in clinical cancer treatment, the combination effects of F. dibotrys-related products with relative therapeutic strategies also worth further evaluation.

Previously, the anti-cancer and anti-oxidant activities of F. dibotrys have attracted most of the attention, while investigation on the pharmacological activities that supporting the folk medicinal usage of F. dibotrys are still insufficient. For example, F. dibotrys has been documented as an important Chinese medicine for its therapeutic effect against pulmonary abscess and pneumonia. However, the potential mechanisms and targets are still unclear. With the development of traditional Chinese medicine and the strengthening of the world’s understanding of traditional Chinese medicine, research on the anti-inflammation, anti-viral and immune-promoting effects of F. dibotrys should be synchronously promoted, and much more work is still needed. Previously, F. dibotrys extracts or monomers are mostly used in the in vivo and in vitro pharmacological studies. Studies have proved that F. dibotrys has a certain effect on pneumonia, enteritis, diabetes, and other diseases. However, in some of the pharmacological studies, the in vivo experimental dose is much too high, and some in vitro experimental administration time is very long, whether these experimental designs are reasonable should be taken into consideration in the future studies.

With developments in biochemistry, people are paying more and more attention to the secondary metabolites when researching medicinal plants. It has been documented that the contents of secondary metabolites in medicinal plants are related with the expression of different functional genes. Therefore, it is critical to start from functional genes to elucidate the biosynthetic pathways and regulatory mechanisms of active ingredients involved in the regulation of secondary metabolites and structure-encoding genes of key enzyme systems [96]. Previously, research into the secondary metabolites of F. dibotrys is mainly concentrated on flavonoids. In subsequent endeavors, research into other secondary metabolites including the polyphenols should be strengthened in order to further clarify the synthetic pathways and regulatory mechanisms of the effective ingredients of F. dibotrys.

In addition to the aforementioned phytochemical and pharmacological studies, F. dibotrys has also received significant attention because of its high nutritional and medicinal value. F. dibotrys seeds are often used as coarse grains and can be made into tea. F. dibotrys leaves can be eaten directly as vegetables [97]. F. dibotrys can be processed into highly nutritious feed or feed additives, and green straw can be used as pasture. Modern food processing technology and equipment may help further development of F. dibotrys related healthy products. More importantly, protection of the wild resources and development of cultivation techniques and genetic analysis will help better development and utilization of this medicinal economic plant.


As a famous edible herbal medicine widely used in traditional Chinese medicine, F. dibotrys has attracted increasing attention in the past decades. To date, more than 100 compounds have been isolated and identified from F. dibotrys, mainly including flavonoids, phenols, steroids, and fatty acids, etc. Pharmacological studies have shown that F. dibotrys possesses anti-inflammatory, anti-cancer, anti-oxidant, anti-bacterial and anti-diabetic activities, which partially support the ethnomedicinal uses of F. dibotrys. Flavonoids and phenolic compounds are considered to be the main active ingredients of F. dibotrys. Additional studies on functional genes have led to a better understanding on the metabolic pathways and regulatory factors related to flavonoid active ingredients in F. dibotrys. Our study provides a comprehensive review regarding the research advances on the phytochemistry and pharmacology of F. dibotrys, as well as the functional genes, aiming to promote further research on F. dibotrys.

Availability of data and materials

Not applicable.


F. dibotrys :

Fagopyrum dibotrys

F. esculentum :

Fagopyrum esculentum

F. tataricum :

Fagopyrum tataricum




Tumor necrosis factor-α




Human peripheral blood mononuclear cells


Acute lung injury






African swine fever virus


Hepatitis virus C


Feline calicivirus


Murine norovirus


Human norovirus


Alzheimer’s disease




Anthocyanin synthase


Dihydroflavonol 4-reductase


Leucoanthocyantin reductase



halcone isomerase


Phenylalanine ammonia lyase


  1. 1.

    Jing R, Li HQ, Hu CL, Jiang YP, Qin LP, Zheng CJ. Phytochemical and pharmacological profiles of three Fagopyrum buckwheats. Int J Mol Sci. 2016;17(4):589.

    PubMed Central  Article  CAS  Google Scholar 

  2. 2.

    Wang X, Zhou T, Bai G, Zhao Y. Complete chloroplast genome sequence of Fagopyrum dibotrys: genome features, comparative analysis and phylogenetic relationships. Sci Rep. 2018;8(1):12379.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  3. 3.

    Chen CX, Li AL. Transcriptome analysis of differentially expressed genes involved in proanthocyanidin accumulation in the rhizomes of Fagopyrum dibotrys and an irradiation-induced mutant. Front Physiol. 2016;7(100):1–18.

    Google Scholar 

  4. 4.

    Ge F, Zhu S, Liu L, Yan J, Sun Z. Antiinflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis. Exp Ther Med. 2017;14(5):4745–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Zhao G, Wang A, Hu Z. Research on the nutrient constituents and medicinal values of Fagopyrum cymosum seeds. Chin Wild Plant Resour. 2002;21(5):39–41.

    Google Scholar 

  6. 6.

    Sinkovič L, Kokalj Sinkovič D, Meglič V. Milling fractions composition of common (Fagopyrum esculentum Moench) and Tartary (Fagopyrum tataricum (L.) Gaertn.) buckwheat. Food Chem. 2021;365:130459.

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Zou L, Wu D, Ren G, Hu Y, Peng L, Zhao J, et al. Bioactive compounds, health benefits, and industrial applications of Tartary buckwheat (Fagopyrum tataricum). Crit Rev Food Sci Nutr. 2021.

    Article  PubMed  Google Scholar 

  8. 8.

    Ruan J, Zhou Y, Yan J, Zhou M, Woo SH, Weng W, et al. Tartary buckwheat: an under-utilized edible and medicinal herb for food and nutritional security. Food Rev Int. 2020.

    Article  Google Scholar 

  9. 9.

    Ohnishi O. Search for the wild ancestor of buckwheat III. The wild ancestor of cultivated common buckwheat, and of tatary buckwheat. Econ Bot. 1998;52(2):123–33.

    Article  Google Scholar 

  10. 10.

    Yasui Y, Ohnishi O. Phylogenetic relationships among Fagopyrum species revealed by the nucleotide sequences of the ITS region of the nuclear rRNA gene. Genes Genet Syst. 1998;73:201–10.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Wang C, Ding M, Zou C, Zhu X, Tang Y, Zhou M, et al. Comparative analysis of four buckwheat species based on morphology and complete chloroplast genome sequences. Sci Rep. 2017;7(1):6514.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  12. 12.

    Yasui Y, Ohnishi O. Interspecific relationships in Fagopyrum (polygonaceae) revealed by the nucleotide sequences of the rbcL and ACCD genes and their intergenic region. Am J Bot. 1998;85(9):1134–42.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Cook N, Samman S. Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996;7(2):66–76.

    CAS  Article  Google Scholar 

  14. 14.

    Tinikul R, Chenprakhon P, Maenpuen S, Chaiyen P. Biotransformation of plant-derived phenolic acids. Biotechnol J. 2018;13(6):e1700632.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Chung KT, Wong TY, Wei C, Huang YW, Lin Y. Tannins and human health: a review. Crit Rev Food Sci Nutr. 1998;38(6):421–64.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Zhao JL, Jiang L, Tang XH, Peng LX, Li X, Zhao G, et al. Chemical composition, antimicrobial and antioxidant activities of the flower volatile oils of Fagopyrum esculentum, Fagopyrum tataricum and Fagopyrum cymosum. Molecules. 2018;23(1):182–91.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  17. 17.

    Shao M, Yang YH, Gao HY, Bin WU, Wang LB, Wu LJ. Studies on the chemical constituents of Fagopyrum dibotrys (D.Don) Hara. J Shenyang Pharm Univ. 2005;22(2):100–2.

    CAS  Google Scholar 

  18. 18.

    Sheng F, Zhang L, Wang S, Yang L, Li P. Deacetyl ganoderic acid F inhibits LPS-Induced neural inflammation via NF-κB pathway both in vitro and in vivo. Nutrients. 2019;12(1):85.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  19. 19.

    Shen YJ, Bian ZL, Shao JG. Effect of Fagopyrum cymosum tablets on the level of inflammatory factor in DSS-induced inflammation model mice. Acta Chin Med. 2019;34(256):1916–20.

    Google Scholar 

  20. 20.

    Liu L, Cai X, Yan J, Luo Y, Cao P. In vivo and in vitro antinociceptive effect of Fagopyrum cymosum (Trev.) Meisn extracts: a possible action by recovering intestinal barrier dysfunction. Evid Based Complement Alternat Med. 2012;2012:983801.

    PubMed  PubMed Central  Google Scholar 

  21. 21.

    Shen L, Wang P, Guo J, Du G. Anti-arthritic activity of ethanol extract of Fagopyrum cymosum with adjuvant-induced arthritis in rats. Pharm Biol. 2013;51(6):783–9.

    PubMed  Article  Google Scholar 

  22. 22.

    Dong LY, Wang CY, Wu CQ, Qin J, Zhang ZF. Protection and mechanism of Fagopyrum cymosum on lung injury in rats with Klebsiella pneumonia. J Chin Med Mater. 2012;35(4):603–7.

    Google Scholar 

  23. 23.

    Aziz N, Kim MY, Cho JY. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. 2018;225:342–58.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Pan CW, Wang W, Qi XZ, Yang JL, Zhou XY. Anti-proliferative and apoptosis-inducing activity of rhizoma fagopyri cymosi extract in cervical cancer Hela cells. Pharmacol Clin Chin Materia Med. 2018;34(5):96–100.

    Google Scholar 

  25. 25.

    Wu JY, Chen YJ, Bai L, Liu YX, Fu XQ, Zhu PL, et al. Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-kappaB and STAT3 pathways. Phytomedicine. 2020;68:153173.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Shalini V, Jayalekshmi A, Helen A. Mechanism of anti-inflammatory effect of tricin, a flavonoid isolated from Njavara rice bran in LPS induced hPBMCs and carrageenan induced rats. Mol Immunol. 2015;66(2):229–39.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Devi Pandima K, Nabavi Mohammad S, Fazel SX, Daglia J, Sureda M. Kaempferol and inflammation: from chemistry to medicine. Pharmacol Res. 2015;99:1–10.

    Article  CAS  Google Scholar 

  28. 28.

    Wu H, Wang J, Zhao Q, Ding Y, Kong L. Protocatechuic acid inhibits proliferation, migration and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Artif Cell Nanomed B. 2020;48(1):969–76.

    CAS  Article  Google Scholar 

  29. 29.

    Ingawale DK, Mandlik SK, Patel SS. Anti-inflammatory potential of hecogenin on atopic dermatitis and airway hyper-responsiveness by regulation of pro-inflammatory cytokines. Immunopharm Immunot. 2019;41(2):327–36.

    CAS  Article  Google Scholar 

  30. 30.

    Jiang YL, Yang WC, Gui SY. Procyanidin B2 protects rats from paraquat-induced acute lung injury by inhibiting NLRP3 inflammasome activation. Immunobiology. 2018;223(10):555–61.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Na W, Ma B, Shi S, Chen Y, An H. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma. Biochem Pharmacol. 2020;178:114089.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Terra X, Palozza P, Fernandez-Larrea J, Ardevol A, Blade C, Pujadas G, et al. Procyanidin dimer B1 and trimer C1 impair inflammatory response signalling in human monocytes. Free Radic Res. 2011;45(5):611–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Chan PK. Inhibition of tumor growth in vitro by the extract of Fagopyrum cymosum (fago-c). Life Sci. 2003;72(16):1851–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Chen XF, Gu ZL. The progress of anti-tumor effect of Fagopyrum dibotrys. Chin Tradit Herb Drugs. 2000;31(9):715–8.

    Google Scholar 

  35. 35.

    Feng CX, Gu ZL, Yang HH. The effect of Fr4 on expression of matrix metalloproteinase-9 and tissue inhibitors of metallproteinase-1 in mouse lewis lung cancer tissue. Acta Acad Med Suzhou. 2005;25(3):383–6.

    Google Scholar 

  36. 36.

    Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen EA, et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med. 2010;2(45):45ra59.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  37. 37.

    Huang MY, Zhang LL, Ding J, Lu JJ. Anticancer drug discovery from Chinese medicinal herbs. Chin Med. 2018;13:35.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  38. 38.

    Guo Q, Zhao B, Shen S, Hou J, Hu J, Xin W. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta. 1999;1427(1):13–23.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    Pradhan M, Suri C, Choudhary S, Naik PK, Lopus M. Elucidation of the anticancer potential and tubulin isotype-specific interactions of β-sitosterol. J Biomol Struct Dyn. 2018;36(1):195–208.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Shay J, Elbaz HA, Lee I, Zielske SP, Malek MH, Huttemann M. Molecular mechanisms and therapeutic effects of (−)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid Med Cell Longev. 2015;2015:181260.

    PubMed  PubMed Central  Article  Google Scholar 

  41. 41.

    Ganesan K, Xu B. Molecular targets of vitexin and isovitexin in cancer therapy: a critical review. Ann NY Acad Sci. 2017;1401(1):102–13.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Lan L, Wang Y, Pan ZY, Wang B, Yue Z, Jiang Z, et al. Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway. Oncol Lett. 2018;17(1):676–82.

    PubMed  PubMed Central  Google Scholar 

  43. 43.

    Wang J, Quan Q, Ji R, Guo X, Zhang J, Li X, et al. Isorhamnetin suppresses PANC-1 pancreatic cancer cell proliferation through S phase arrest. Biomed Pharmacother. 2018;108:925–33.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  44. 44.

    Li H, Zhao X, Wang J, Dong Y, Meng S, Li R, et al. β-Sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection. Sci Rep. 2015;5(1):17668.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Wolfram J, Scott B, Boom K, Shen J, Borsoi C, Suri K, et al. Hesperetin liposomes for cancer therapy. Curr Drug Deliv. 2016;13(5):711–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Imran M, Salehi B, Sharifi-Rad J, Gondal TA, Estevinho LM. Kaempferol: a key emphasis to its anticancer potential. Molecules. 2019;24(12):2277.

    CAS  PubMed Central  Article  Google Scholar 

  47. 47.

    Yin R, Li T, Tian J, Xi P, Liu RH. Ursolic acid, a potential anticancer compound for breast cancer therapy. Crit Rev Food Sci Nutr. 2018;58(4):568–74.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Mackenzie GG, Adamo AM, Decker NP, Oteiza PI. Dimeric procyanidin B2 inhibits constitutively active NF-κB in Hodgkin’s lymphoma cells independently of the presence of IκB mutations. Biochem Pharmacol. 2008;75(7):1461–71.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Li X, Liu J, Chang Q, Zhou Z, Han R, Liang Z. Antioxidant and antidiabetic activity of proanthocyanidins from Fagopyrum dibotrys. Molecules. 2021;26(9):2417.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Wang KJ, Zhang YJ, Yang CR. Antioxidant phenolic constituents from Fagopyrum dibotrys. J Ethnopharmacol. 2005;99(2):259–64.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Li G, Yu S, Zhou YH, Chen QF. Analysis of the antioxidant related substances in leaves of the Fagopyrum cumosum complex and common buckwheat plants. Guangdong Agric Sci. 2013;40(7):7–11.

    Google Scholar 

  52. 52.

    Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2015;29(3):323–31.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Zduńska K, Dana A, Kolodziejczak A, Rotsztejn H. Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol Phys. 2018;31(6):332–6.

    Article  CAS  Google Scholar 

  54. 54.

    Yang B, Li XP, Ni YF, Du HY, Wang R, Li MJ, et al. Protective effect of isorhamnetin on lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2015;39(1):129–37.

    Article  CAS  Google Scholar 

  55. 55.

    Sakano K, Mizutani M, Murata M, Oikawa S, Hiraku Y, Kawanishi S. Procyanidin B2 has anti- and pro-oxidant effects on metal-mediated DNA damage. Free Radic Bio Med. 2005;39(8):1041–9.

    CAS  Article  Google Scholar 

  56. 56.

    Wang LB, Shao M, Gao HY. Study on bacteriostasis of Fagopyrum cymosum Meisn. Chin J Microecol. 2005;17:330–1.

    Google Scholar 

  57. 57.

    Bi CH, Gao XH, Zhang QQ. Therapeutic efficacy of fagopyrum cymosum tablet combined with levofloxacin on acute bacillary dysentery. Infect Dis Inf. 2012;25(1):31–3.

    Google Scholar 

  58. 58.

    Wang H, Tang C, Yue H. Studies on antibacterial function of superfine powder Fagopyrum dibotryis in vivo in mice. Prog Vet Med. 2013;34(10):130–2.

    Google Scholar 

  59. 59.

    Olesen SW, Lipsitch M, Grad YH. The role of “spillover” in antibiotic resistance. Proc Natl Acad Sci USA. 2020;117(46):29063–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Ding K, Tan YY, Ding Y, Fang Y, Yang X, Fang J, et al. β-Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria. J Cell Biochem. 2018;120(4):5687–94.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  61. 61.

    Li L, Song X, Yin Z, Jia R, Li Z, Zhou X, et al. The antibacterial activity and action mechanism of emodin from Polygonum cuspidatum against Haemophilus parasuis in vitro. Microbiol Res. 2016;186–187:139–45.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  62. 62.

    Ojha D, Patil KN. p-Coumaric acid inhibits the Listeria monocytogenes RecA protein functions and SOS response: an antimicrobial target. Biochem Biophys Res Commun. 2019;517(4):655–61.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  63. 63.

    Zheng QQ, Lin Y, Xie KQ. Anti-influenza virus (H1N1) effect of garlic oil in vitro. Chin J Public Health. 2013;29(7):593–6.

    Google Scholar 

  64. 64.

    Lalani P. Flavonoids as antiviral agents for enterovirus A71 (EV-A71). Viruses. 2020;12(2):184.

    CAS  PubMed Central  Article  Google Scholar 

  65. 65.

    Zhao Y, Liu Y, Xie S, Wu Q. Study on the anti-influenza virus of extracts from Fagopyrum Dibotrys (D. Don) Hara in vitro. Chin J Mod Appl Pharm. 2019;36(21):2648–51.

    Google Scholar 

  66. 66.

    Astghik H, Arabyan E, Kotsinyan A, et al. Inhibition of African swine fever virus infection by genkwanin. Antivir Res. 2019;167:78–82.

    Article  CAS  Google Scholar 

  67. 67.

    Yazawa K, Kurokawa M, Obuchi M, Li Y, Yamada R, Sadanari H, et al. Anti-influenza virus activity of tricin, 4′,5,7-trihydroxy-3′,5′-dimethoxyflavone. Antivir Chem Chemother. 2011;22(1):1–11.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  68. 68.

    Tohmé MJ, Giménez MC, Peralta A, Colombo MI, Delgui LR. Ursolic acid: a novel antiviral compound inhibiting rotavirus infection in vitro. Int J Antimicrob Agents. 2019;54(5):601–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  69. 69.

    Li S, Kodama EN, Inoue Y, Tani H, Matsuura Y, Zhang J, et al. Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication. Antivir Chem Chemother. 2010;20(6):239–48.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  70. 70.

    Liu D, Deng J, Joshi S, Liu P, Zhang C, Yu Y, et al. Monomeric catechin and dimeric procyanidin B2 against human norovirus surrogates and their physicochemical interactions. Food Microbiol. 2018;76:346–53.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  71. 71.

    Kaneto H, Katakami N, Matsuhisa M, Matsuoka T-A. Role of reactive oxygen speciesin the progression of type2 diabete sand atherosclerosis. Mediat Inflamm. 2010;2010:453892.

    Article  CAS  Google Scholar 

  72. 72.

    Ruan HS, Ji T, Ji WW, Ma SW, Zhang ZY. Effects of flavonoids from Fagopyri dibotryis rhizoma on the glycolipid metabolism and antioxidation in type 2 diabetic rats. Pharmacol Clin Chin Materia Med. 2017;33(5):73–6.

    Google Scholar 

  73. 73.

    Ramírez-Rodríguez AM, González-Ortiz M, Martínez-Abundis E, Acuña Ortega N. Effect of ursolic acid on metabolic syndrome, insulin sensitivity, and inflammation. J Med Food. 2017;20(9):882–6.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  74. 74.

    Sun P, Li K, Wang T, Ji J, Wang Y, Chen K, et al. Procyanidin C1, a component of cinnamon extracts, is a potential insulin sensitizer that targets adipocytes. J Agr Food Chem. 2019;67(32):8839–46.

    CAS  Article  Google Scholar 

  75. 75.

    Abdel-Moneim A, El-Twab SMA, Yousef AI, Reheim ESA, Ashour MB. Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: the role of adipocytokines and PPAR gamma. Biomed Pharmacother. 2018;105:1091–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Bao P, Zhang XR, Zhou XM, Ding CX, Liang XN, Li SM. Pharmacodynamic research of Fagopyrum dibotrys (D.Don) Hara extract. Modern Chin Med. 2009;11:36–41.

    CAS  Google Scholar 

  77. 77.

    Liang C, Yuan JP, Ding T, Yan L, Ling L, Zhou XF, et al. Neuroprotective effect of Fagopyrum dibotrys extract against Alzheimer’s disease. Evid Based Complement Alternat Med. 2017;2017:3294586.

    PubMed  PubMed Central  Google Scholar 

  78. 78.

    Kang YL, Pei J, Cai WL, Liu W, Wu QH. Research progress on flavonoid metabolic synthesis pathway and related function genes in medicinal plants. Chin Tradit Herb Drugs. 2014;45(9):1336–41.

    CAS  Google Scholar 

  79. 79.

    Ma M, Xu X, Zhou L, Li L, Zeng W, Wu YO. Studies on mutagenicity and anti-mutation of Fagopyrum cymosum (Trev) Meisn. Pharmacol Clin Chin Materia Med. 1989;5(6):29–37.

    Google Scholar 

  80. 80.

    Lima LKF, Pereira SKS, Junior RDSS, Santos FPDS, Rai M. A brief review on the neuroprotective mechanisms of vitexin. Biomed Res Int. 2018;2018:4785089.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  81. 81.

    Antonella S, Daniela G, Marta DC. Ferulic acid: a hope for Alzheimer’s disease therapy from plants. Nutrients. 2015;7(7):5764–82.

    Article  CAS  Google Scholar 

  82. 82.

    Taylor S, Aimee W, Noelle P, Daniel L. Procyanidin B2 protects neurons from oxidative, nitrosative, and excitotoxic stress. Antioxidants. 2017;6(4):77.

    Article  CAS  Google Scholar 

  83. 83.

    Song JH, Lee HJ, Kang KS. Procyanidin C1 activates the Nrf2/HO-1 signaling pathway to prevent glutamate-induced apoptotic HT22 cell death. Int J Mol Sci. 2019;20(1):142.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  84. 84.

    Liu CS, Liu Y. Research ideas and prospects of functional genes involved in medicinal plants, such as glycyrrhizae radix et rhizoma. Chin J Exp Tradit Med Formulae. 2015;21(1):1–6.

    Google Scholar 

  85. 85.

    Sun LY, Yu ZJ, Li HY, Li JB, Liu HZ, Lin XF, et al. Advances in secondary metabolites of medicinal plant. J Jilin Agric Sci. 2009;34(2):4–10.

    Google Scholar 

  86. 86.

    Luo XP, Bai YC, Gao F, Li CL, Wu Q. Gene cloning and expression level of chalcone isomerase during florescence and content of flavonoids in Fagopyrum dibotrys. Chin Tradit Herb Drugs. 2013;44(11):1481–5.

    CAS  Google Scholar 

  87. 87.

    Liu GD, Lei XH, Zhu QL, Zhong GC, Guo TY, Li YD, et al. Cloning and sequence analysis of a DFR gene from Fagopyrum dibotrys (D.Don) Hara. Sci Agric Sin. 2009;42(1):55–63.

    CAS  Google Scholar 

  88. 88.

    Ma J, Wang B, Dai Y, Sui SZ, Li MY. Clong and expression analysis of leucoanthocyanidin reductase gene in Fagopyrum dibotrys. Acta Pharm Sin. 2012;47(7):953–61.

    CAS  Google Scholar 

  89. 89.

    Bu XX, Ju XP, Bai YC, Li CL, Chen H, Wu Q. Gene cloning of anthocyanin synthase in Fagopyrum dibotrys and correlation between its expression level and anthocyanin content. Chin Tradit Herb Drugs. 2014;45(7):985–9.

    CAS  Google Scholar 

  90. 90.

    Thiyagarajan K, Vitali F, Tolaini V, Galeffi P, Cantale C, Vikram P, et al. Genomic characterization of phenylalanine ammonia lyase gene in buckwheat. PLoS ONE. 2016;11(3):151–87.

    Article  CAS  Google Scholar 

  91. 91.

    Turnbull J, Nakajima J, Welford R, Yamazaki M, Saito K, Schofield C. Mechanistic studies on three 2-oxoglutarate-dependent oxygenases of flavonoid biosynthesis: anthocyanidin synthase, flavonol synthase, and flavanone 3beta-hydroxylase. J Biol Chem. 2004;279(2):1206–16.

    CAS  PubMed  Article  Google Scholar 

  92. 92.

    Falcone Ferreyra ML, Rius S, Emiliani J, Pourcel L, Feller A, Morohashi K, et al. Cloning and characterization of a UV-B-inducible maize flavonol synthase. Plant J. 2010;62(1):77–91.

    PubMed  Article  CAS  Google Scholar 

  93. 93.

    Jiang J, Bai YC, Li CL, Chen H. Cloning of flavonol synthase gene from Fagopyum dibotrys and its expression in Escherichia coli. Chin Tradit Herb Drugs. 2013;43(1):1974–8.

    Google Scholar 

  94. 94.

    Jing M, Zhu Q, Guo T, Liu G, Li M. Cloning and molecular characteristics analysis of a MYB gene from Fagopyrum dibotrys. China J Chin Materia Med. 2009;34(17):2155–9.

    Google Scholar 

  95. 95.

    Zhang LL, Huang MY, Yang Y, Huang MQ, Shi JJ, Zou L, et al. Bioactive platycodins from Platycodonis Radix: phytochemistry, pharmacological activities, toxicology and pharmacokinetics. Food Chem. 2020;327:127029.

    CAS  PubMed  Article  Google Scholar 

  96. 96.

    Yang XW, Zhang Y, Li LY. Advances in studies on medicinal plant of Fagopyrum dibotrys. Modern Chin Med. 2019;21(6):837–46.

    Google Scholar 

  97. 97.

    Yuankuan HE, Zhao W, Jie MA, Min J, Cheng N, Deng L, et al. Optimization of high-yield cultivation technique in Fagopyrum dibotrys. Guizhou Agric Sci. 2016;44(1):52–5.

    Google Scholar 

Download references


Not applicable.


This work was supported by the Open Project of Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China (2020GZ2011009) and Health and Family Planning Commission of Chengdu-Key Disciplines of Clinical Pharmacy.

Author information




LLZ and YH drafted the manuscript. YH, FS, and YFH collected literatures. YS, WL, JC, and JZ participated in the revision and improvement of the manuscript. LLZ, FS, and LZ conceived and designed the review. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Feiya Sheng or Liang Zou.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, LL., He, Y., Sheng, F. et al. Towards a better understanding of Fagopyrum dibotrys: a systematic review. Chin Med 16, 89 (2021).

Download citation


  • Fagopyrum dibotrys
  • Phytochemistry
  • Pharmacology
  • Functional genes
  • Active ingredients